ALXO FY 2019 Earnings — ALX Oncology Holdings Inc. Revenue & Financial Results | Market Cap Arena

ALXOALX Oncology Holdings Inc.

$113M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+132.0% YoY

Gross Profit

$436,0009.1% margin

Operating Income

-$19M-400.0% margin

Net Income

-$19M-401.2% margin

EPS (Diluted)

$-0.88

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$15M

Stock-Based Comp.

$297,000

Balance Sheet

Total Assets

$11M

Total Liabilities

$11M

Stockholders' Equity

-$276,000

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$2M	+132.0%
Gross Profit	$436,000	$187,000	+133.2%
Operating Income	-$19M	-$14M	-40.2%
Net Income	-$19M	-$14M	-40.1%